Cefamandole nafate therapy in the treatment of acute urinary tract infections

Cefamandole nafate, a new cephalosporin antibiotic, was used to treat acute urinary tract infection in 31 patients, of whom 26 had pyelonephritis and 5 had cystitis. Eleven of these patients had underlying diseases or complicating factors present which frequently alter clinical response to therapy....

Full description

Saved in:
Bibliographic Details
Published in:Journal of antimicrobial chemotherapy 1976-12, Vol.2 (4), p.345-350
Main Authors: Short, H. D., Gentry, L. O., Sessoms, S.
Format: Article
Language:English
Subjects:
Acute Disease
Adolescent
Adult
Aged
Cefamandole - administration & dosage
Cefamandole - blood
Cefamandole - therapeutic use
Cephalosporins - therapeutic use
Clinical Trials as Topic
Female
Humans
Male
Middle Aged
Time Factors
Urinary Tract Infections - drug therapy
Urinary Tract Infections - etiology
Urinary Tract Infections - microbiology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c236t-4f903543f29418351b6ce1ec4bda78957e3712c0b68914de49c526d4e737f12b3
cites
container_end_page 350
container_issue 4
container_start_page 345
container_title Journal of antimicrobial chemotherapy
container_volume 2
creator Short, H. D.
Gentry, L. O.
Sessoms, S.
description Cefamandole nafate, a new cephalosporin antibiotic, was used to treat acute urinary tract infection in 31 patients, of whom 26 had pyelonephritis and 5 had cystitis. Eleven of these patients had underlying diseases or complicating factors present which frequently alter clinical response to therapy. Relapse or reinfection occurred with equal frequency in both complicated and uncomplicated groups.
doi_str_mv 10.1093/jac/2.4.345
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_83807191</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>83807191</sourcerecordid><originalsourceid>FETCH-LOGICAL-c236t-4f903543f29418351b6ce1ec4bda78957e3712c0b68914de49c526d4e737f12b3</originalsourceid><addsrcrecordid>eNo9kEtLw0AUhQfxVasrty6yciNp55lMllqsFSqCKBQ3w2RyB1ObpM5MwP57p6S4uhe-j8PhIHRN8ITggk3X2kzphE8YF0doRHiGU4oLcoxGmGGR5lywc3Th_RpjnIlMnqFTiSmhYoReZmB1o9uq20DSaqsDJOELnN7ukrrdv0lwoEMDbUg6m2jTR6N3davdLiJtQvQsmFB3rb9EJ1ZvPFwd7hh9zB_fZ4t0-fr0PLtfpoayLKTcFpgJziwtOJFMkDIzQMDwstK5LEQOLCfU4DKTBeEV8MIImlUccpZbQks2RrdD7tZ1Pz34oJraG9hsdAtd75VkEuekIFG8G0TjOu8dWLV1dROrK4LVfjsVt1NUcRW3i_bNIbYvG6j-3WGsiNMB1z7A7z_V7ltlsZlQi9WnehMPUs5XUuXsD8JLeJM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>83807191</pqid></control><display><type>article</type><title>Cefamandole nafate therapy in the treatment of acute urinary tract infections</title><source>Oxford University Press Archive</source><creator>Short, H. D. ; Gentry, L. O. ; Sessoms, S.</creator><creatorcontrib>Short, H. D. ; Gentry, L. O. ; Sessoms, S.</creatorcontrib><description>Cefamandole nafate, a new cephalosporin antibiotic, was used to treat acute urinary tract infection in 31 patients, of whom 26 had pyelonephritis and 5 had cystitis. Eleven of these patients had underlying diseases or complicating factors present which frequently alter clinical response to therapy. Relapse or reinfection occurred with equal frequency in both complicated and uncomplicated groups.</description><identifier>ISSN: 0305-7453</identifier><identifier>EISSN: 1460-2091</identifier><identifier>DOI: 10.1093/jac/2.4.345</identifier><identifier>PMID: 802125</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Acute Disease ; Adolescent ; Adult ; Aged ; Cefamandole - administration &amp; dosage ; Cefamandole - blood ; Cefamandole - therapeutic use ; Cephalosporins - therapeutic use ; Clinical Trials as Topic ; Female ; Humans ; Male ; Middle Aged ; Time Factors ; Urinary Tract Infections - drug therapy ; Urinary Tract Infections - etiology ; Urinary Tract Infections - microbiology</subject><ispartof>Journal of antimicrobial chemotherapy, 1976-12, Vol.2 (4), p.345-350</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c236t-4f903543f29418351b6ce1ec4bda78957e3712c0b68914de49c526d4e737f12b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/802125$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Short, H. D.</creatorcontrib><creatorcontrib>Gentry, L. O.</creatorcontrib><creatorcontrib>Sessoms, S.</creatorcontrib><title>Cefamandole nafate therapy in the treatment of acute urinary tract infections</title><title>Journal of antimicrobial chemotherapy</title><addtitle>J Antimicrob Chemother</addtitle><description>Cefamandole nafate, a new cephalosporin antibiotic, was used to treat acute urinary tract infection in 31 patients, of whom 26 had pyelonephritis and 5 had cystitis. Eleven of these patients had underlying diseases or complicating factors present which frequently alter clinical response to therapy. Relapse or reinfection occurred with equal frequency in both complicated and uncomplicated groups.</description><subject>Acute Disease</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Cefamandole - administration &amp; dosage</subject><subject>Cefamandole - blood</subject><subject>Cefamandole - therapeutic use</subject><subject>Cephalosporins - therapeutic use</subject><subject>Clinical Trials as Topic</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Time Factors</subject><subject>Urinary Tract Infections - drug therapy</subject><subject>Urinary Tract Infections - etiology</subject><subject>Urinary Tract Infections - microbiology</subject><issn>0305-7453</issn><issn>1460-2091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1976</creationdate><recordtype>article</recordtype><recordid>eNo9kEtLw0AUhQfxVasrty6yciNp55lMllqsFSqCKBQ3w2RyB1ObpM5MwP57p6S4uhe-j8PhIHRN8ITggk3X2kzphE8YF0doRHiGU4oLcoxGmGGR5lywc3Th_RpjnIlMnqFTiSmhYoReZmB1o9uq20DSaqsDJOELnN7ukrrdv0lwoEMDbUg6m2jTR6N3davdLiJtQvQsmFB3rb9EJ1ZvPFwd7hh9zB_fZ4t0-fr0PLtfpoayLKTcFpgJziwtOJFMkDIzQMDwstK5LEQOLCfU4DKTBeEV8MIImlUccpZbQks2RrdD7tZ1Pz34oJraG9hsdAtd75VkEuekIFG8G0TjOu8dWLV1dROrK4LVfjsVt1NUcRW3i_bNIbYvG6j-3WGsiNMB1z7A7z_V7ltlsZlQi9WnehMPUs5XUuXsD8JLeJM</recordid><startdate>197612</startdate><enddate>197612</enddate><creator>Short, H. D.</creator><creator>Gentry, L. O.</creator><creator>Sessoms, S.</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>197612</creationdate><title>Cefamandole nafate therapy in the treatment of acute urinary tract infections</title><author>Short, H. D. ; Gentry, L. O. ; Sessoms, S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c236t-4f903543f29418351b6ce1ec4bda78957e3712c0b68914de49c526d4e737f12b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1976</creationdate><topic>Acute Disease</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Cefamandole - administration &amp; dosage</topic><topic>Cefamandole - blood</topic><topic>Cefamandole - therapeutic use</topic><topic>Cephalosporins - therapeutic use</topic><topic>Clinical Trials as Topic</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Time Factors</topic><topic>Urinary Tract Infections - drug therapy</topic><topic>Urinary Tract Infections - etiology</topic><topic>Urinary Tract Infections - microbiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Short, H. D.</creatorcontrib><creatorcontrib>Gentry, L. O.</creatorcontrib><creatorcontrib>Sessoms, S.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of antimicrobial chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Short, H. D.</au><au>Gentry, L. O.</au><au>Sessoms, S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cefamandole nafate therapy in the treatment of acute urinary tract infections</atitle><jtitle>Journal of antimicrobial chemotherapy</jtitle><addtitle>J Antimicrob Chemother</addtitle><date>1976-12</date><risdate>1976</risdate><volume>2</volume><issue>4</issue><spage>345</spage><epage>350</epage><pages>345-350</pages><issn>0305-7453</issn><eissn>1460-2091</eissn><abstract>Cefamandole nafate, a new cephalosporin antibiotic, was used to treat acute urinary tract infection in 31 patients, of whom 26 had pyelonephritis and 5 had cystitis. Eleven of these patients had underlying diseases or complicating factors present which frequently alter clinical response to therapy. Relapse or reinfection occurred with equal frequency in both complicated and uncomplicated groups.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>802125</pmid><doi>10.1093/jac/2.4.345</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0305-7453
ispartof Journal of antimicrobial chemotherapy, 1976-12, Vol.2 (4), p.345-350
issn 0305-7453
1460-2091
language eng
recordid cdi_proquest_miscellaneous_83807191
source Oxford University Press Archive
subjects Acute Disease
Adolescent
Adult
Aged
Cefamandole - administration & dosage
Cefamandole - blood
Cefamandole - therapeutic use
Cephalosporins - therapeutic use
Clinical Trials as Topic
Female
Humans
Male
Middle Aged
Time Factors
Urinary Tract Infections - drug therapy
Urinary Tract Infections - etiology
Urinary Tract Infections - microbiology
title Cefamandole nafate therapy in the treatment of acute urinary tract infections
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T01%3A06%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cefamandole%20nafate%20therapy%20in%20the%20treatment%20of%20acute%20urinary%20tract%20infections&rft.jtitle=Journal%20of%20antimicrobial%20chemotherapy&rft.au=Short,%20H.%20D.&rft.date=1976-12&rft.volume=2&rft.issue=4&rft.spage=345&rft.epage=350&rft.pages=345-350&rft.issn=0305-7453&rft.eissn=1460-2091&rft_id=info:doi/10.1093/jac/2.4.345&rft_dat=%3Cproquest_cross%3E83807191%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c236t-4f903543f29418351b6ce1ec4bda78957e3712c0b68914de49c526d4e737f12b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=83807191&rft_id=info:pmid/802125&rfr_iscdi=true